salvin has been researched along with Disease Models, Animal in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 21 (77.78) | 24.3611 |
| 2020's | 5 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, Y; Qin, Q; Su, Z; Wang, Y; Xiao, J; Xie, L; Zhang, Y | 1 |
| Bing, Y; Chun-Yan, W; Fei-Tong, J; Le, K; Minghong, W; Ping, S; Qi, Z; Xiang, L; Xiangxiang, Z; Yan, L; Ye, X; Yi-Bin, W; Yufei, G | 1 |
| Chen, B; He, L; Liang, L; Xiao, C; Zhu, M | 1 |
| Ahmed, A; Azhar, M; Choudhary, MI; Dar Farooq, A; De-Jiang, J; Liu, X; Zeng, G | 1 |
| Cheng, ZN; Jiang, DJ; Tang, YH; Wang, XQ; Wu, LF; Zeng, GR; Zhou, YJ | 1 |
| Fu, M; Qin, Y; Sun, H; Wang, X; Xia, G | 1 |
| Han, X; Lipton, SA; Lopez, KM; McKercher, SR; Nagar, S; Nakanishi, N; Noveral, SM; Okamoto, SI; Piña-Crespo, JC; Satoh, T; Trudler, D; Yates, JR | 1 |
| de Oliveira, MR | 1 |
| Cheng, J; Li, H; Liu, M; Liu, Z; Qiu, H; Wu, L; Xu, J; Yuan, J; Zhao, J; Zhou, L; Zhou, X | 1 |
| Alizadeh, A; Amini, N; Babahajian, A; Entezari, M; Golab, F; Haramshahi, SMA; Katebi, M; Rasoolijazi, H; Sarveazad, A; Soleimani, M; Vahabzadeh, G | 1 |
| Arora, R; Baliga, MS; Bhat, NR; Jimmy, R; Palatty, PL; Rao, P; Rao, S; Saldanha, E; Sunitha, V; Thilakchand, KR | 1 |
| Kuncha, M; Putcha, UK; Rachamalla, SS; Sahu, BD; Sistla, R | 1 |
| Hall, ED; Miller, DM; Singh, IN; Wang, JA | 1 |
| Chang, SW; Huang, LC; Lin, CY; Tsai, CW; Wu, CR | 1 |
| Ambasudhan, R; Dolatabadi, N; Lee, B; Lipton, SA; Masliah, E; McKercher, SR; Newmeyer, T; Nutter, A; Parker, J; Sanz-Blasco, S; Song, P; Zhang, D | 1 |
| Akcilar, R; Altuntas, I; Bayat, Z; Isiklar, OO; Kocak, C; Kocak, FE; Kocak, H; Simsek, H; Taser, F | 1 |
| Akasaka, T; Maesawa, C; Masuda, T; Okubo, A; Shibazaki, M; Takahashi, K; Yasuhira, S | 1 |
| Hao, L; Lu-Qun, W; Ran, W; Xiang-Xin, L; Xiao-Ning, Y | 1 |
| Bifulco, G; Bisio, A; Cantone, V; Chini, MG; Koeberle, A; Maione, F; Mascolo, N; Pace, S; Pieretti, S; Romussi, G; Werz, O | 1 |
| Bahri, S; Jameleddine, S; Shlyonsky, V | 1 |
| Bellumori, M; Cravotto, G; Di Cesare Mannelli, L; Ghelardini, C; Innocenti, M; Maresca, M; Micheli, L; Mulinacci, N | 1 |
| Kosaka, K; Lipton, SA; Lopez, KM; Masliah, E; McKercher, SR; Nakanishi, N; Nutter, A; Parker, J; Rezaie, T; Satoh, T | 1 |
| Amichay, D; Barvish, Z; Danilenko, M; Kafka, M; Levy, J; Shabtay, A; Sharabani, H; Sharoni, Y; Studzinski, GP; Uskokovic, MR | 1 |
| Pertino, MW; Rodríguez, JA; Schmeda-Hirschmann, G; Theoduloz, C | 1 |
| Kuncha, M; Putcha, UK; Rentam, KK; Sahu, BD; Sistla, R; Vegi, GM | 1 |
| Chun, T; Joshi, R; Kosaka, K; Lipton, SA; McKercher, SR; Rezaie, T; Sasaki, S; Satoh, T; Seki, M; Tozawa, T; Valencia, M; Viswanath, V; Wheeler, L | 1 |
| El Omri, A; Han, J; Isoda, H; Kondo, S; Sasaki, K | 1 |
3 review(s) available for salvin and Disease Models, Animal
| Article | Year |
|---|---|
Carnosic Acid as a Promising Agent in Protecting Mitochondria of Brain Cells.
Topics: Abietanes; Animals; Biological Products; Brain; Disease Models, Animal; Humans; Mitochondria; Neuroprotective Agents | 2018 |
Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer.
Topics: Abietanes; Animals; Apigenin; Cinnamates; Depsides; Disease Models, Animal; Drug Evaluation, Preclinical; Eugenol; Humans; Luteolin; Neoplasms; Ocimum; Phytochemicals; Plant Extracts; Plants, Medicinal; Rosmarinic Acid; Sitosterols | 2013 |
Relevance of carnosic acid to the treatment of several health disorders: Molecular targets and mechanisms.
Topics: Abietanes; Animals; Anti-Obesity Agents; Antineoplastic Agents, Phytogenic; Biological Availability; Dermatologic Agents; Disease Models, Animal; Gastrointestinal Agents; Humans; Neuroprotective Agents | 2016 |
24 other study(ies) available for salvin and Disease Models, Animal
| Article | Year |
|---|---|
Carnosic acid ameliorated Aβ-mediated (amyloid-β peptide) toxicity, cholinergic dysfunction and mitochondrial defect in
Topics: Abietanes; Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cholinergic Agents; Disease Models, Animal; Mitochondria; Paralysis; Peptide Fragments; Vesicular Acetylcholine Transport Proteins | 2022 |
Inhibition of the CEBPβ-NFκB interaction by nanocarrier-packaged Carnosic acid ameliorates glia-mediated neuroinflammation and improves cognitive function in an Alzheimer's disease model.
Topics: Abietanes; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cognition; Disease Models, Animal; Inflammation; Interleukin-6; Mice; Mice, Transgenic; Microglia; Neuroinflammatory Diseases; Presenilin-1; Tumor Necrosis Factor-alpha | 2022 |
Protective effects of carnosic acid on retinal ganglion cells in acute ocular hypertension rats.
Topics: Abietanes; Animals; Disease Models, Animal; Glaucoma; Intraocular Pressure; Male; Ocular Hypertension; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells | 2020 |
Carnosic acid ameliorates depressive-like symptoms along with the modulation of FGF9 in the hippocampus of middle carotid artery occlusion-induced Sprague Dawley rats.
Topics: Abietanes; Animals; Brain; Carotid Arteries; Depression; Disease Models, Animal; Fibroblast Growth Factor 9; Hippocampus; Male; Rats; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 3; Stroke; Swimming | 2021 |
Carnosic acid alleviates depression-like behaviors on chronic mild stressed mice via PPAR-γ-dependent regulation of ADPN/FGF9 pathway.
Topics: 3T3-L1 Cells; Abietanes; Adipocytes; Adiponectin; Animals; Antidepressive Agents; Behavior, Animal; Brain; Depression; Disease Models, Animal; Down-Regulation; Fibroblast Growth Factor 9; Male; Mice; Mice, Inbred ICR; Mice, Knockout; PPAR gamma; Receptors, Adiponectin; Signal Transduction; Up-Regulation | 2021 |
Carnosic acid (CA) attenuates collagen-induced arthritis in db/db mice via inflammation suppression by regulating ROS-dependent p38 pathway.
Topics: Abietanes; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Humans; Immunosuppression Therapy; Inflammation; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Osteoclasts; Reactive Oxygen Species; Rosmarinus | 2017 |
MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress.
Topics: Abietanes; Animals; Disease Models, Animal; Haploinsufficiency; Light; MEF2 Transcription Factors; Mice; NF-E2-Related Factor 2; Oxidative Stress; Photoreceptor Cells, Vertebrate; Reactive Oxygen Species; Retinal Degeneration | 2017 |
Carnosic acid inhibits inflammation response and joint destruction on osteoclasts, fibroblast-like synoviocytes, and collagen-induced arthritis rats.
Topics: Abietanes; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone Resorption; Cell Line; Collagen; Cytokines; Disease Models, Animal; Female; Fibroblasts; Humans; Inflammation; Inflammation Mediators; Joints; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Rats; Rats, Wistar; RAW 264.7 Cells; Rosmarinus; Synovial Membrane; Synoviocytes | 2018 |
Neuroprotective Effects of Trolox, Human Chorionic Gonadotropin, and Carnosic Acid on Hippocampal Neurodegeneration After Ischemiareperfusion Injury.
Topics: Abietanes; Animals; Apoptosis; Chorionic Gonadotropin; Chromans; Disease Models, Animal; Hippocampus; Humans; Mice; Neurodegenerative Diseases; Neuroprotective Agents; Reperfusion Injury | 2019 |
Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice.
Topics: Abietanes; Active Transport, Cell Nucleus; Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Diseases; Isoproterenol; Lipid Peroxidation; Male; Mice; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Plant Extracts | 2014 |
Nrf2-ARE activator carnosic acid decreases mitochondrial dysfunction, oxidative damage and neuronal cytoskeletal degradation following traumatic brain injury in mice.
Topics: Abietanes; Adenosine Diphosphate; Aldehydes; Analysis of Variance; Animals; Antioxidants; Brain; Brain Injuries; Cytoskeleton; Disease Models, Animal; Dose-Response Relationship, Drug; Lipid Peroxidation; Male; Mice; Mitochondrial Diseases; Oxidative Stress; Plant Extracts; Succinic Acid | 2015 |
Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction.
Topics: Abietanes; Animals; Antioxidants; bcl-2-Associated X Protein; Blotting, Western; Cell Line, Tumor; Disease Models, Animal; Glutamate-Cysteine Ligase; Glutathione Reductase; Humans; Male; Motor Activity; Oxidopamine; Parkinson Disease; Plant Extracts; Poly(ADP-ribose) Polymerases; Random Allocation; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2015 |
Protection from cyanide-induced brain injury by the Nrf2 transcriptional activator carnosic acid.
Topics: Abietanes; Animals; Antioxidants; Bioterrorism; Brain; Brain Injuries; Cyanides; Disease Models, Animal; Humans; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Plant Extracts; Rats; Rats, Sprague-Dawley | 2015 |
Molecular and biochemical evidence on the protective effects of embelin and carnosic acid in isoproterenol-induced acute myocardial injury in rats.
Topics: Abietanes; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzoquinones; Cardiotonic Agents; Disease Models, Animal; Gene Expression Regulation; Isoproterenol; Male; Myocardial Infarction; Rats; Rats, Wistar; RNA, Messenger | 2016 |
NAD(P)H dehydrogenase, quinone 1 (NQO1), protects melanin-producing cells from cytotoxicity of rhododendrol.
Topics: Abietanes; Animals; Apoptosis; Butanols; Cell Death; Cell Line, Tumor; Cytoprotection; Disease Models, Animal; Humans; Indoleacetic Acids; Melanins; Melanocytes; Mice; NAD(P)H Dehydrogenase (Quinone); Transcription, Genetic | 2016 |
Carnosic Acid-combined Arsenic Trioxide Antileukaemia Cells in the Establishment of NB4/SCID Mouse Model.
Topics: Abietanes; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mice; Mice, SCID; Oxides; PTEN Phosphohydrolase; RNA, Messenger | 2016 |
Anti-inflammatory and analgesic activity of carnosol and carnosic acid in vivo and in vitro and in silico analysis of their target interactions.
Topics: Abietanes; Analgesics; Animals; Anti-Inflammatory Agents; Computer Simulation; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Lipoxygenase Inhibitors; Male; Mice; Molecular Docking Simulation; Monocytes; Neutrophils; Pain; Prostaglandin-E Synthases; Salvia | 2017 |
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: relevance of nicotinic receptors.
Topics: Abietanes; Analgesics, Non-Narcotic; Animals; Chemical Fractionation; Disease Models, Animal; Mecamylamine; Neuralgia; Neuroprotective Agents; Nicotinic Antagonists; Plant Extracts; Rats, Sprague-Dawley; Receptors, Nicotinic; Rosmarinus; Sciatic Nerve; Solvents; Spinal Cord; Terpenes | 2016 |
Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models.
Topics: Abietanes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidant Response Elements; Biomarkers; Cells, Cultured; Cerebral Cortex; Dendritic Spines; Disease Models, Animal; Glial Fibrillary Acidic Protein; Gliosis; Humans; Immunohistochemistry; Mice, Transgenic; Models, Biological; Neutrophils; NF-E2-Related Factor 2; Rats; Signal Transduction; Spatial Learning; Staining and Labeling; Synapses; Synaptophysin | 2016 |
Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.
Topics: Abietanes; Animals; Antioxidants; Bone Marrow; Calcitriol; Cell Differentiation; Cell Proliferation; Cholecalciferol; Disease Models, Animal; Drug Synergism; Humans; Immunoblotting; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Mice, Inbred BALB C; Plant Extracts; Reactive Oxygen Species; Rosmarinus; Survival Rate; Tumor Cells, Cultured | 2008 |
Gastroprotective effect and cytotoxicity of carnosic acid derivatives.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Animals; Anti-Ulcer Agents; Antioxidants; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Lansoprazole; Male; Methylation; Mice; Plant Components, Aerial; Plant Extracts; Random Allocation; Rosmarinus; Stomach Ulcer; Structure-Activity Relationship | 2011 |
Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
Topics: Abietanes; Acute Kidney Injury; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Blood Urea Nitrogen; Caspase 3; Catalase; Cisplatin; Creatinine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Kidney; Lipid Peroxidation; Malondialdehyde; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 2011 |
Protective effect of carnosic acid, a pro-electrophilic compound, in models of oxidative stress and light-induced retinal degeneration.
Topics: Abietanes; Animals; Antioxidants; Blood-Brain Barrier; Cell Line; Disease Models, Animal; Disease Progression; Electroretinography; Light; Oxidative Stress; Photoreceptor Cells, Vertebrate; Plant Extracts; Rats; Rats, Sprague-Dawley; Retinal Degeneration; Rosmarinus | 2012 |
Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation.
Topics: Abietanes; Animals; Antidepressive Agents; Cinnamates; Depressive Disorder; Depsides; Disease Models, Animal; Mice; Neurons; PC12 Cells; Phytotherapy; Plant Extracts; Pyruvate Carboxylase; Rats; Rosmarinic Acid; Rosmarinus; Tyrosine 3-Monooxygenase; Up-Regulation | 2013 |